Fine-Tuning Your Multichannel Marketing Strategy
In today’s pharmaceutical industry, it seems there are nearly as many communication channels as there are instruments in the Philharmonic.
In today’s pharmaceutical industry, it seems there are nearly as many communication channels as there are instruments in the Philharmonic, and a similar level of coordination is needed to ensure multichannel success.
Then, there’s the added challenge of managing interactions with today’s multifaceted customer, who could be a government agent; payer; physician (primary, specialist, or key opinion leader); nurse; hospital administrator; or Considering all the complexity in today’s life sciences industry, hitting the right note is much more difficult than just communicating through all channels. It requires a tremendous amount of coordination between sales, marketing and medical affairs.
In this article, Jan van den Burg looks at what companies need to do to execute a multichannel strategy that’s always in tune with the customer.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.
